Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
RevImmune advances new immunotherapy in COVID-19 2020-11-02 21:00
Clarivate Expands International Real-World Data Offering with Addition of Techtrials Brazilian Dataset 2020-11-02 21:00
GP(HK) Enters into A Few Agreements in the Field of Cancer Diagnostics and Treatment 2020-11-02 17:01
PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors 2020-10-30 20:00
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases 2020-10-30 10:54
AGC Biologics and Horizon Therapeutics plc Expand Partnership 2020-10-30 03:17
Daewoong Pharmaceutical Partners with Tufts Medical Center for Phase 2 Clinical Trial with Niclosamide 2020-10-29 21:00
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms 2020-10-29 19:00
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia 2020-10-29 09:35
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate 2020-10-29 07:15
BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures 2020-10-29 02:51
Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus 2020-10-28 22:36
Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards 2020-10-28 21:00
I-Mab Announces Upcoming Participation at November Conferences 2020-10-28 20:00
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments 2020-10-28 20:00
Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019 2020-10-28 17:04
APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia 2020-10-28 14:00
Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic' 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
1 275 276 277 278 279 412